Dietmar Berger
President bij INHIBRX, INC.
Profiel
Dietmar P. Berger bekleedt de functie van Chief Medical Officer & Global Head-Development bij Sanofi. In zijn vorige carrière was hij Global Head-Research & Development bij Atara Biotherapeutics, Inc., Head-Clinical Research Centre aan de Universittsklinikum Freiburg, Vice President-Clinical Hematology & Oncology bij Genentech, Inc. en Head-Clinical Research Centre aan The Scripps Research Institute. Dr. Berger behaalde een doctoraal en een doctoraat aan de Universiteit van Freiburg.
Actieve functies van Dietmar Berger
| Bedrijven | Functie | Begin |
|---|---|---|
| SANOFI | Hoofd Techniek/Wetenschap/O&O | 01-01-2019 |
| INHIBRX, INC. | President | 30-05-2024 |
Eerdere bekende functies van Dietmar Berger
| Bedrijven | Functie | Einde |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 31-05-2019 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01-05-2018 |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | - |
Universitätsklinikum Freiburg
 Universitätsklinikum Freiburg Hospital/Nursing ManagementHealth Services Universitätsklinikum Freiburg operates as a teaching hospital. The company was founded by Archduke Albrecht VI in 1457 and is headquartered in Freiburg, Germany. | Corporate Officer/Principal | - |
Opleiding van Dietmar Berger
| University of Freiburg | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| SANOFI | Health Technology |
| INHIBRX, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Universitätsklinikum Freiburg
Universitätsklinikum Freiburg Hospital/Nursing ManagementHealth Services Universitätsklinikum Freiburg operates as a teaching hospital. The company was founded by Archduke Albrecht VI in 1457 and is headquartered in Freiburg, Germany. | Health Services |
